Sponsor or institution

Clinical trials and research at Bayer

• 41Clinical trials
• 47Countries

Newest trials

All recruiting trials (41)

• Acoramidis in adults with transthyretin amyloid cardiomyopathy in France

  This is an observational study to see how acoramidis is used in everyday care for adults with ATTR‑CM in France and how it affects their quality of life and daily function.

  Recruiting Bayer · Many Locations · NCT07791160

• How your body handles two forms of elinzanetant in healthy women

  This study tests whether a new tablet form of elinzanetant is absorbed and processed by the bodies of healthy women in the same way as an existing capsule form.

  Recruiting Phase 1 Bayer · Mount Royal, Quebec · NCT07762287

• Heart-risk in older men with advanced prostate cancer treated with enzalutamide or darolutamide

  This observational study tests whether heart-related risks differ for older men with advanced prostate cancer treated with enzalutamide or darolutamide.

  Recruiting Bayer · Whippany, New Jersey · NCT07672119

• How safe BAY3389934 is when given alone or with aspirin in healthy adults

  This study tests BAY3389934, alone and with aspirin, to see if it’s safe and how it affects blood clotting in healthy adults.

  Recruiting Phase 1 Bayer · Miami, Florida · NCT07652723

• BAY 3670549 in Atrial Fibrillation: Does it help restore normal rhythm after AF episode?

  This study tests BAY 3670549 against a placebo in adults with atrial fibrillation who need electrical cardioversion to see if it helps restore normal heart rhythm and how safe it is.

  Recruiting at 9 sites Phase 2 Bayer · San Francisco, California and 29 other locations · NCT07625215

• Finerenone in adults with CKD and type 2 diabetes in Spain: real-world changes in kidney risk score

  This observational study tests how finerenone affects a kidney-risk score in adults with CKD linked to type 2 diabetes who are already taking finerenone in routine care in Spain.

  Recruiting Bayer · Many Locations · NCT07554469

• Darolutamide plus ADT for men with non-metastatic prostate cancer that progressed after prior ADT+bicalutamide

  This study tests whether adding darolutamide to ongoing androgen deprivation therapy helps men with non-metastatic castration-resistant prostate cancer who previously progressed on bicalutamide plus ADT.

  Recruiting Bayer · Multiple Locations · NCT07538843

• BAY 3771249 for advanced colorectal cancer with KRAS G12D mutation

  This trial will test whether BAY 3771249, alone or with cetuximab, helps people with advanced or metastatic colorectal cancer that has a KRAS G12D mutation.

  Recruiting at 6 sites Phase 1 Bayer · Phoenix, Arizona and 20 other locations · NCT07535112

• Darolutamide plus hormone therapy before prostate removal for men with high-risk localized prostate cancer

  This study tests whether adding darolutamide to standard hormone (androgen-deprivation) therapy for 12 or 24 weeks before prostate removal helps men with high-risk localized prostate cancer.

  Recruiting at 17 sites Phase 2 Bayer · Hefei, Anhui and 22 other locations · NCT07450599

• How darolutamide with hormone therapy works for advanced prostate cancer in German practice

  This observational study looks at how well darolutamide added to hormone therapy works for German men with metastatic hormone-sensitive prostate cancer who are already starting this combination in routine care.

  Recruiting Bayer · Locations · NCT07395804

• Safety of finerenone in adults with chronic heart failure (LVEF ≥ 40%) in South Korea

  This project will see if finerenone is safe for adults in South Korea who have chronic heart failure with a left ventricular ejection fraction of 40% or higher while they take it as usual care.

  Recruiting Bayer · Multiple Locations · NCT07379840

• Darolutamide with hormone therapy (± chemotherapy) in metastatic hormone-sensitive prostate cancer

  This real-world study tests whether darolutamide plus hormone therapy, with or without chemotherapy, helps men with metastatic hormone-sensitive prostate cancer achieve very low PSA levels and stay safe.

  Recruiting at 10 sites Bayer · Many Locations and 15 other locations · NCT07344779

• How Parkinson's changes over time in people whose movement symptoms persist despite medication

  This project will follow people with Parkinson's who still have movement symptoms despite medication to see how their symptoms and health records change over time.

  Recruiting at 7 sites Bayer · Phoenix, Arizona and 26 other locations · NCT07330258

• Measuring how common neovascular AMD, diabetic macular edema, and retinal vein occlusion are in Germany using health insurance data

  This project will use two large German health databases from 2009–2024 to find out how often people with nAMD, DME, or RVO are diagnosed and how many people currently have these conditions in Germany.

  Recruiting Bayer · Leverkusen · NCT07308639

• Switching from tafamidis to acoramidis to see how transthyretin blood levels change

  This test will see if switching people with transthyretin amyloid cardiomyopathy who are taking tafamidis to acoramidis raises transthyretin levels in the blood.

  Recruiting at 10 sites Phase 4 Bayer · Sankt Pölten, Lower Austria and 25 other locations · NCT07298044

• Hydrotalcite (Talcid) for relief of rebound acid symptoms after stopping long-term PPI therapy

  We are trying hydrotalcite (Talcid) to see if it relieves rebound acid symptoms in adults who have stopped long-term PPI treatment.

  Recruiting Bayer · Multiple Locations · NCT07291700

• Acoramidis for transthyretin amyloid cardiomyopathy in routine care

  See how acoramidis works for adults with transthyretin amyloid cardiomyopathy (wild-type or variant) when given as part of regular clinical care.

  Recruiting at 17 sites Bayer · Multiple Locations and 16 other locations · NCT07235462

• Use of anti-androgen medicines in men with metastatic hormone-sensitive prostate cancer in Australia

  This project looks at prescription records to see how androgen receptor pathway inhibitor medicines are being used with hormone therapy in adult men in Australia who have metastatic hormone-sensitive prostate cancer.

  Recruiting Bayer · Pymble, New South Wales · NCT07223372

• Safe, long-term finerenone for children and young adults with heart failure and LV dysfunction

  This study tests whether finerenone can be safely used over a long period in children and young adults who have heart failure due to left ventricular systolic dysfunction.

  Recruiting at 13 sites Phase 3 Bayer · Aurora, Colorado and 131 other locations · NCT07192952

• Finerenone versus placebo added to usual care for children with heart failure and reduced left ventricular pumping

  This will test whether finerenone, given with standard heart-failure treatment, helps children aged 6 months to under 18 with reduced left ventricular function compared with placebo.

  Recruiting at 20 sites Phase 3 Bayer · Aurora, Colorado and 132 other locations · NCT07188805

• Damoctocog alfa pegol in previously treated children with Hemophilia A

  This is a watching-the-treatment study to see how damoctocog alfa pegol works in kids aged 7 to under 12 who have Hemophilia A and have been treated before.

  Recruiting Bayer · Loma Linda, California and 11 other locations · NCT07088458

• Testing the safety of BAY 3713372 in patients with specific solid tumors

  This study is testing a new drug called BAY 3713372 to see if it's safe for people with specific solid tumors that have a certain genetic change and who have already tried other treatments.

  Recruiting at 45 sites Phase 1/2 Bayer · Birmingham, Alabama and 62 other locations · NCT06914128

• Evaluating the safety and dosage of BAY 3389934 for treating sepsis-induced coagulopathy

  This study is testing a new medication called BAY 3389934 to see if it is safe and what the right dose is for people with blood clotting problems caused by sepsis.

  Recruiting at 8 sites Phase 1 Bayer · Aurora, Colorado and 20 other locations · NCT06854640

• Understanding how kidney injury develops after heart surgery

  This study is trying to understand how kidney injury happens after heart surgery in patients who use a heart-lung machine, to help improve care for this common problem.

  Recruiting at 4 sites Bayer · Bad Oeynhausen, North Rhine-Westphalia and 3 other locations · NCT06772025

• Testing a new drug for advanced liver cancer

  This study is testing a new drug for advanced liver cancer to see if it can safely target cancer cells while sparing healthy tissue.

  Recruiting at 28 sites Phase 1 Bayer · Dothan, Alabama and 35 other locations · NCT06764316

• Treatment for solid tumors with HER2 mutations using BAY2927088 tablets

  This study is testing if BAY2927088 tablets can help people with advanced solid tumors that have HER2 gene mutations feel better and manage their cancer.

  Recruiting at 33 sites Phase 2 Bayer · Birmingham, Alabama and 53 other locations · NCT06760819

• Observing the safety and effectiveness of darolutamide with hormone therapy and chemotherapy for Japanese men with low-volume metastatic prostate cancer

  This study looks at how safe and effective a combination of darolutamide, hormone therapy, and chemotherapy is for Japanese men with low-volume metastatic prostate cancer.

  Recruiting Bayer · Many Locations · NCT06661122

• Combining BAY3498264 with Sotorasib for Advanced Solid Cancers with KRAS G12C Mutation

  This study is testing a new drug called BAY3498264 combined with Sotorasib to see if it can help people with advanced solid cancers that have a specific KRAS G12C mutation.

  Recruiting at 10 sites Phase 1 Bayer · Albury, New South Wales and 10 other locations · NCT06659341

• Evaluating BAY 2927088 for Advanced Lung Cancer with HER2 Mutations

  This study is testing a new drug called BAY 2927088 to see if it can help people with advanced lung cancer that has specific HER2 mutations feel better compared to standard treatments.

  Recruiting at 37 sites Phase 3 Bayer · Newport Beach, California and 278 other locations · NCT06452277

• Observing the safety of darolutamide in Korean men with prostate cancer

  This study is testing the safety of darolutamide in Korean men with prostate cancer to see how well it works as part of their regular treatment.

  Recruiting Bayer · Many Locations · NCT06334120

• Collecting data on the use of Aflibercept in preterm babies with eye condition

  This study is looking at how well Aflibercept works for treating eye problems in preterm babies with retinopathy of prematurity by collecting information from hospitals across the UK.

  Recruiting Bayer · Many Locations · NCT06315556

• Observational study on the use of finerenone for chronic kidney disease and type 2 diabetes

  This study looks at how well finerenone works and how safe it is for people with chronic kidney disease and type 2 diabetes who are already taking it as part of their regular treatment.

  Recruiting Bayer · Many Locations, New Jersey and 3 other locations · NCT06278207

• Observing the safety of damoctocog-alfa-pegol in Korean patients with hemophilia A

  This study is looking at how safe the hemophilia A treatment damoctocog alfa pegol is for Korean patients aged 12 and older who are already using it as part of their regular care.

  Recruiting Bayer · Multiple Locations · NCT06222697

• New treatment for advanced prostate cancer using radiation therapy

  This study is testing a new radiation treatment for men with advanced prostate cancer to see if it is safe and effective at stopping cancer growth.

  Recruiting at 20 sites Phase 1 Bayer · Duarte, California and 34 other locations · NCT06217822

• Observational study on vericiguat use in Korean patients with chronic heart failure

  This study looks at how well vericiguat works and its safety for Korean adults with chronic heart failure who are already receiving their usual treatment.

  Recruiting Bayer · Multiple Locations · NCT06148935

• Observing the safety of vericiguat in Japanese patients with chronic heart failure

  This study is testing how safe the drug vericiguat is for Japanese patients with chronic heart failure as they use it in their regular treatment.

  Recruiting Bayer · Multiple Locations, Many Locations · NCT05666518

• Long-term safety of Finerenone for children with chronic kidney disease

  This study is testing the long-term safety of a medication called Finerenone in children and young adults with chronic kidney disease to see how it works when used with other common treatments.

  Recruiting at 23 sites Phase 3 Bayer · Phoenix, Arizona and 150 other locations · NCT05457283

• Evaluating the safety and effectiveness of Darolutamide with standard hormone therapy for prostate cancer

  This study is testing if adding Darolutamide to standard hormone therapy can help men with high-risk prostate cancer that keeps progressing even when testosterone is low.

  Recruiting at 11 sites Phase 4 Bayer · Nadiād, Gujarat and 14 other locations · NCT05348876

• First-in-human test of BAY2927088 for advanced NSCLC with EGFR and/or HER2 mutations

  This study tests BAY2927088 to see if it is safe and tolerable in people with advanced NSCLC that carry EGFR or HER2 mutations.

  Recruiting at 3 sites Phase 1/2 Bayer · Gilbert, Arizona and 93 other locations · NCT05099172

• Using larotrectinib for advanced or recurrent solid tumors with NTRK gene fusion

  This study is testing how well larotrectinib works for adults and children with advanced or recurrent solid tumors caused by NTRK gene fusions.

  Recruiting Bayer · Multiple Locations · NCT04945330

• Safety assessment of Aflibercept injection in Japanese patients with neovascular glaucoma

  This study is testing if Aflibercept can safely help Japanese patients with neovascular glaucoma over six months.

  Recruiting Bayer · Multiple Locations · NCT04519619

Quick answers

How many clinical trials run by Bayer are recruiting right now?

41, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 47 countries. The most sites are in United States (16 trials), Italy (15 trials), Belgium (14 trials), Germany (14 trials), Spain (14 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 7, Phase 3: 4, Phase 2: 3, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →